U.S., Jan. 7 -- An application to own the trademark for 'LOHYPTO' has been filed on Mar. 31, 2025.
Owner(s):
Mineralys Therapeutics, Inc.; 150 N. Radnor Chester Road, Suite F200, , PENNSYLVANIA
Goods and/or Services:
For: Pharmaceutical preparations for the prevention and treatment of hypertension, sleep apnea, chronic kidney disease, heart failure, primary aldosteronism, myocardial infarction, coronary artery disease, blood vessel wall thickening, renal fibrosis, nephropathy, and vascular dementia
Class(es): 005, 006, 018, 044, 046, 051, 052
Mark Drawing Type: 4 - STANDARD CHARACTER MARK
https://eog-tmng.uspto.gov/#/issueDate=2026-01-06&serialNumber=99112441
Disclaimer: Curated by HT Syndication....